symptomatic treatment of venous-lymphatic insufficiency (heaviness in the legs, pain, night cramps) - functional symptoms associated with acute attacks of hemorrhoids.
Hesperidin + Diosmin has an angioprotective and venotonic effect. Reduces the distensibility of veins, increases their tone and reduces venous stagnation, reduces permeability, capillary fragility and increases their resistance, improves microcirculation and lymphatic drainage. When used systematically, it reduces the severity of clinical manifestations of chronic venous insufficiency of the lower extremities of an organic and functional nature. The optimal dose-effect ratio is observed when taking 1000 mg per day.
Amlisect reduces total peripheral vascular resistance, blood pressure (BP), preload and afterload.
Amlisect reduces total peripheral vascular resistance, blood pressure (BP), preload and afterload.
Parsolet is a powerful antidepressant that is effective in the treatment of obsessive-compulsive (OCD) and panic disorder. Does not cause significant changes in blood pressure, heart rate and EEG.
Primary and secondary carnitine deficiency in adults, children, including infants and newborns - secondary levocarnitine deficiency in adult patients with end-stage kidney disease who have been on hemodialysis for a long time and have the following conditions: severe persistent muscle spasms, muscle weakness and/or myopathy, muscle loss weight caused by malnutrition symptoms of arterial hypotension during dialysis decreased quality of life associated with lack of energy cardiomyopathy anemia with uremia, in the absence of treatment effect or requiring large doses of erythropoietin.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
$180.85$350.99
Syndicate customized growth strategies prospective human capital leverage other's optimal e-markets without transparent catalysts for change. Credibly coordinate highly efficient methods of empowerment cross unit solutions.
In 1991, a team of professionals with fundamental knowledge and competencies entered the pharmaceutical supply market - this was the EVOLET company.
Our accumulated experience in distribution, marketing, outsourcing and manufacturing of pharmaceutical products, an innovative approach to managing and optimizing business processes has given us the opportunity to enter the international market and become an example of an ambitious, ethical company in 30 countries in less than a quarter of a century.
EVOLET GROUP maintains strong partnerships with leading manufacturers and distributors, gradually expanding the range of its competencies. By 2011, this allowed us to cover almost the full range of services in the pharmaceutical field and develop further.